Patrick Forde
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Patrick Forde
Jun 29, 2024, 15:03 |
Insight
IO inductive therapy let 25% unresectable stage 3 NSCLC become resectable
Thomas Wu, Research physician at Genentech, shared a post by X: "Our paper just out…
Jun 27, 2024, 12:11 |
Insight
Patrick Forde: What is an acceptable rate of crossover?
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
Jun 26, 2024, 14:53 |
Blog
Patrick Forde: Consensus recommendations from IASLC for lung cancer
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
Jun 5, 2024, 11:51 |
Blog
Patrick Forde: Initial thoughts I will bring back to clinic from ASCO24
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
Jun 2, 2024, 08:46 |
Blog
Patrick Forde: Michael Conroy awarded an ASCO Conquer Cancer Young Investigator Award
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer…
May 14, 2024, 16:10 |
Blog
Luis E. Raez: Unfortunatly adding IO to chemo/radiation is not working but we have other options
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post by Patrick Forde, Co-Director of…
May 9, 2024, 06:46 |
Societies
12 Posts Not To Miss From The 3rd International Summit on Lung Cancer!
The 3rd International Summit on Lung Cancer (RomeLung24), organized by the International Association for the…
Apr 29, 2024, 15:02 |
Blog
Patrick Forde: 3 lung cancer plenaries at ASCO24!
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
Mar 21, 2024, 15:19 |
Blog
Jarushka Naidoo: Getting ready to plan ASCO24
Jarushka Naidoo shared a post on X/Twitter: “Getting ready to plan ASCO24! And with a…
Mar 11, 2024, 18:00 |
Societies
Florez Lab: A fantastic discussion on Nivolumab and Non-Small Cell Lung Cancer
Florez Lab posted on X/Twitter: "What podcast should you listen to today? In this episode…
1
2
All:
14
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube